Intellectual Property Office Home University of Cincinnati
Issued US Patents
UC Technology Startups
Our Mission
IP Overview
Policies and Law
Annual Reports
Staff and Location
Contact Us
UC Directory
IPO Home

Case Number 108011 - Marrow Manager

Description:  Definitive and palliative radiation therapy affects normal bone marrow and can have implications regarding the safety of administering chemotherapy. Whether a patient has received radiotherapy prior to, following, or concurrently with chemotherapy, the amount of bone marrow irradiated can have implications relative to a patient's blood counts and risk of infection, bleeding and/or anemia. The radiation bone marrow quotient computer program allows the radiation fields to be drawn on a diagram of a human skeleton and the percentage of bone marrow irradiated is quickly ascertained.
The effect of the radiation on the bone marrow and the blood counts will be the function of the volume of bone marrow irradiated, the dose of the radiation delivered, the health of the bone marrow radiated, and the baseline blood counts at the the time of treatment.

For more information please contact Geoffrey Pinski at 513-558-5696 or

Back to Technologies
Printer Friendly Version of Marrow Manager - 108011

Copyright Information © Copyright 2004-2012 university of Cincinnati, Ohio. All rights reserved.